Neutralization of VOCs including Delta one year post COVID-19 or vaccine
Sebastian Havervall, Ulrika Marking, Max Gordon, Henry Ng, Nina Greilert-Norin, Sarah Lindbo, Kim Blom, Peter Nilsson, Mia Phillipson, Jonas Klingström, Sara Mangsbo, Mikael Åberg, Sophia Hober, Charlotte Thålin
doi: https://doi.org/10.1101/2021.08.12.21261951
Sebastian Havervall
1Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
MDUlrika Marking
1Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
MDMax Gordon
1Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
MD, PhDHenry Ng
1Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
2Department of Medical Cell Biology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden
MMScNina Greilert-Norin
1Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
RNSarah Lindbo
3Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
PhDKim Blom
4Public Health Agency of Sweden, Solna, Sweden
PhDPeter Nilsson
3Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
PhDMia Phillipson
2Department of Medical Cell Biology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden
PhDJonas Klingström
4Public Health Agency of Sweden, Solna, Sweden
5Centre for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
PhDSara Mangsbo
6Department of Pharmaceutical Biosciences and Science for Life Laboratory, Uppsala University, Uppsala, Sweden
PhDMikael Åberg
7Department of Medical Sciences, Clinical Chemistry and Science for Life Laboratory, Uppsala University, Uppsala, Sweden
PhDSophia Hober
3Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
PhDCharlotte Thålin
1Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
MD, PhD![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted August 15, 2021.
Neutralization of VOCs including Delta one year post COVID-19 or vaccine
Sebastian Havervall, Ulrika Marking, Max Gordon, Henry Ng, Nina Greilert-Norin, Sarah Lindbo, Kim Blom, Peter Nilsson, Mia Phillipson, Jonas Klingström, Sara Mangsbo, Mikael Åberg, Sophia Hober, Charlotte Thålin
medRxiv 2021.08.12.21261951; doi: https://doi.org/10.1101/2021.08.12.21261951
Neutralization of VOCs including Delta one year post COVID-19 or vaccine
Sebastian Havervall, Ulrika Marking, Max Gordon, Henry Ng, Nina Greilert-Norin, Sarah Lindbo, Kim Blom, Peter Nilsson, Mia Phillipson, Jonas Klingström, Sara Mangsbo, Mikael Åberg, Sophia Hober, Charlotte Thålin
medRxiv 2021.08.12.21261951; doi: https://doi.org/10.1101/2021.08.12.21261951
Subject Area
Subject Areas
- Addiction Medicine (342)
- Allergy and Immunology (665)
- Anesthesia (180)
- Cardiovascular Medicine (2625)
- Dermatology (222)
- Emergency Medicine (397)
- Epidemiology (12175)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4064)
- Geriatric Medicine (385)
- Health Economics (676)
- Health Informatics (2625)
- Health Policy (997)
- Hematology (360)
- HIV/AIDS (845)
- Medical Education (398)
- Medical Ethics (109)
- Nephrology (430)
- Neurology (3832)
- Nursing (209)
- Nutrition (570)
- Oncology (2008)
- Ophthalmology (581)
- Orthopedics (238)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (471)
- Pediatrics (1107)
- Primary Care Research (447)
- Public and Global Health (6499)
- Radiology and Imaging (1390)
- Respiratory Medicine (869)
- Rheumatology (400)
- Sports Medicine (338)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)